Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Einstein (Säo Paulo) ; 10(1): 105-119, jan.-mar. 2012. tab
Article in English, Portuguese | LILACS | ID: lil-621520

ABSTRACT

Clostridium difficile is the main cause of nosocomial diarrhea. Diarrhea associated with C. difficile has increased incidence, morbidity, and mortality in the last few years. The major related risk factors include use of antibiotics, elderly patients and prolonged hospital stay. Many patients receive combinations of antibiotics or multiple antibiotics, which represents the main risk to develop diarrhea associated to C. difficile or its recurrence. Therefore, interventions to improve antibiotic prescribing, as well as compliance with infection control measures can reduce hospital-acquired C. difficile infections. This review addresses the epidemiological changes in C. difficile disease and its treatment.


Clostridium difficile é a principal causa de diarreia hospitalar. A diarreia por C. difficile aumentou sua incidência e sua morbiletalidade nos últimos anos. Os principais fatores de risco relacionados são uso de antibióticos, idosos e permanência hospitalar prolongada. Muitos pacientes recebem combinação de antibióticos ou múltiplos antibióticos, constituindo-se, assim, o principal fator de risco para o desenvolvimento de infecção ou de recorrência de diarreia associada ao C. difficile. Por isso, intervenções que otimizem a prescrição de antibióticos associado à aderência de medidas de controle de infecção podem reduzir aquisição dessa infecção. Assim, esta revisão aborda a mudança da epidemiologia da infecção por C. difficile e seu tratamento.


Subject(s)
Humans , Clostridium Infections/epidemiology , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Brazil/epidemiology , Clostridium Infections/diagnosis , Clostridium Infections/drug therapy , Clostridium Infections/microbiology , Clostridium Infections/physiopathology , Clostridioides difficile/drug effects , Clostridioides difficile/isolation & purification , Cross Infection/epidemiology , Cross Infection/microbiology , Diarrhea/epidemiology , Diarrhea/microbiology , Disease Susceptibility , Drug Resistance, Multiple, Bacterial , Enterocolitis, Pseudomembranous/epidemiology , Enterocolitis, Pseudomembranous/microbiology , Immunotherapy , Morbidity/trends , Probiotics/therapeutic use , Recurrence , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL